http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008297272-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d75d1a4caed60a9316608ed9c231546c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 |
filingDate | 2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dee9e256bb51ee3e927d426784efc72b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_489d3c1831aac6ee8411a5b75b1e0a7f |
publicationDate | 2008-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2008297272-A |
titleOfInvention | Regulation of CD40 expression using c-MIR and screening method thereof |
abstract | Disclosed are a drug having a novel mechanism of action and various means for developing them. A substance capable of modulating the expression of CD40, and / or an immune disease, comprising assessing whether a subject can modulate (eg, promote, suppress) c-MIR expression or activity. Examples, screening methods for substances capable of preventing or treating autoimmune diseases such as arthritis and immunodeficiency diseases; agents that regulate the expression of CD40, and / or immune diseases, including substances that can regulate the expression or activity of c-MIR Preventive or therapeutic agent. According to the present invention, it becomes possible to prevent or treat an immune disease that does not suppress acquired immune function. [Selection figure] None |
priorityDate | 2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.